Campion Asset Management’s Eli Lilly LLY Stock Holding History

Campion Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.22M	Sell	2,683 -49	-2%	-$50.1K	1.96%	14
2026 Q1	$2.51M	Sell	2,732 -170	-6%	-$172K	1.7%	16
2025 Q4	$3.12M	Sell	2,902 -46	-2%	-$44K	2.17%	15
2025 Q3	$2.25M	Sell	2,948 -30	-1%	-$22.3K	1.6%	16
2025 Q2	$2.32M	Sell	2,978 -74	-2%	-$57.5K	1.74%	16
2025 Q1	$2.52M	Sell	3,052 -155	-5%	-$129K	1.95%	16
2024 Q4	$2.48M	Sell	3,207 -133	-4%	-$110K	1.87%	16
2024 Q3	$2.96M	Sell	3,340 -25	-0.7%	-$22.5K	2.17%	14
2024 Q2	$3.05M	Hold	3,365	–	–	2.4%	14
2024 Q1	$2.62M	Sell	3,365 -10	-0.3%	-$7.12K	2.02%	14
2023 Q4	$1.97M	Hold	3,375	–	–	1.67%	16
2023 Q3	$1.81M	Hold	3,375	–	–	1.67%	17
2023 Q2	$1.58M	Sell	3,375 -100	-3%	-$41.9K	1.41%	17
2023 Q1	$1.19M	Sell	3,475 -25	-0.7%	-$8.43K	1.13%	18
2022 Q4	$1.28M	Sell	3,500 -300	-8%	-$106K	1.26%	17
2022 Q3	$1.23M	Sell	3,800 -15	-0.4%	-$4.75K	1.3%	17
2022 Q2	$1.24M	Sell	3,815 -25	-0.7%	-$7.5K	1.22%	17
2022 Q1	$1.1M	Sell	3,840 -125	-3%	-$32.2K	0.94%	21
2021 Q4	$1.09M	Hold	3,965	–	–	0.91%	19
2021 Q3	$916K	Sell	3,965 -25	-0.6%	-$6.17K	0.82%	22
2021 Q2	$916K	Sell	3,990 -1,790	-31%	-$360K	0.76%	22
2021 Q1	$1.08M	Buy	+5,780	New	+$1.13M	0.82%	22

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Campion Asset Management's LLY Position: Q2 2026 in Review

Campion Asset Management reduced its Eli Lilly (LLY) stake by 1.8% in Q2 2026, selling an estimated $50.1K and leaving 2,683 shares worth $3.22M. The position accounts for 1.96% of the portfolio, ranked #14.

Campion Asset Management first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Campion Asset Management held 2,683 shares of Eli Lilly worth $3.22M as of Q2 2026.
Campion Asset Management sold 49 Eli Lilly shares in Q2 2026, an estimated $50.1K.
Eli Lilly made up 1.96% of Campion Asset Management's portfolio in Q2 2026, its #14 holding.
Campion Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Campion Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.